isoxanthochymol has been researched along with 2,2',4,4'-tetrahydroxybenzophenone in 1 studies
| Studies (isoxanthochymol) | Trials (isoxanthochymol) | Recent Studies (post-2010) (isoxanthochymol) | Studies (2,2',4,4'-tetrahydroxybenzophenone) | Trials (2,2',4,4'-tetrahydroxybenzophenone) | Recent Studies (post-2010) (2,2',4,4'-tetrahydroxybenzophenone) |
|---|---|---|---|---|---|
| 9 | 0 | 3 | 41 | 0 | 23 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Efferth, T; Kuete, V; Moungang, ML; Murayama, T; Ngadjui, BT; Ngameni, B; Tala, MF; Tchakam, PD; Wabo, HK; Wiench, B | 1 |
1 other study(ies) available for isoxanthochymol and 2,2',4,4'-tetrahydroxybenzophenone
| Article | Year |
|---|---|
Cytotoxicity and modes of action of four naturally occuring benzophenones: 2,2',5,6'-tetrahydroxybenzophenone, guttiferone E, isogarcinol and isoxanthochymol.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Benzophenones; Carcinoma; Caspases; Cell Proliferation; Colonic Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; HCT116 Cells; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia; Matrix Metalloproteinases; Neoplasms; Phenotype; Phytotherapy; Plant Extracts; Reactive Oxygen Species | 2013 |